Acquisition · 11 August 2026Redcliffe LabsOmnichannel diagnostic service providerredcliffelabs.com ↗
AcquisitionHealthcare & Life Sciences
Redcliffe Labs acquires Megavision Diagnostics for ₹40 crore
By Abha Lohia · Editor ·
Redcliffe Labs: revenue and funding and every story →
Noida
- Redcliffe Labs is an omnichannel diagnostic service provider headquartered in Noida
- It acquired Pune-based Megavision Diagnostics Center for approximately ₹40 crore, adding two MRI-equipped centres
- The acquisition is part of Redcliffe's strategy to expand integrated diagnostics across Western India
What happened
- Redcliffe Labs has acquired Megavision Diagnostics Center in Pune for approximately ₹40 crore.
- Megavision runs two MRI-equipped centres in Pune's Pimpri-Chinchwad area and has served the region for over two decades.
- The acquisition adds advanced imaging (MRI) capabilities to Redcliffe's pathology network.
- Redcliffe retains Megavision's entire workforce.
- Founder and director Dr Kedar Prabhakar Bhate continues to lead the business as Megavision Redcliffe Labs.
- Dr Bhate will work with Redcliffe's Clinical Board to strengthen radiology services.
- Redcliffe did not disclose the purchase price in its formal announcement.
Why it matters
- The acquisition comes amid consolidation in India's diagnostics sector in 2026.
- In May 2026, Dr Lal PathLabs acquired Shahbazkers Diagnostic Centre for up to ₹20 crore.
- Also in May 2026, MedGenome acquired a majority stake in Siddhi Diagnostics & Research Centre.
- Neuberg Diagnostics acquired a controlling stake in NM Medical (18 centres across Mumbai, Pune, Bengaluru).
- Diagnostic players are moving towards integrated platforms combining pathology, radiology, imaging, genomics, and preventive healthcare.
The business
- Redcliffe Labs is an omnichannel diagnostic service provider headquartered in Noida.
- It offers pathology, radiology, imaging, genomics (GeneCliffe), and preventive healthcare packages.
- Redcliffe provides home sample collection, temperature-controlled sample transport, and doctor-verified smart reports.
- It has a she-centric diagnostic platform called Femcliffe.
- Redcliffe has served more than 1 crore customers to date.
- It operates across more than 220 cities with over 80 owned laboratories.
- Its network covers more than 4,000 pincodes and offers more than 3,600 diagnostic tests.
- Redcliffe has 1,500+ trained phlebotomists and 2,000+ collection centres.
The founders
DJ
Dheeraj Jain
Chairman & FounderIn numbers
₹40 croreAcquisition value · 2026
1 crore+Customers served to date · 2026
220+Cities of operation · 2026
80+Owned laboratories · 2026
4,000+Pincodes covered · 2026
3,600+Diagnostic tests offered · 2026
1,500+Trained phlebotomists · 2026
2,000+Collection centres · 2026
What happens next
- Redcliffe plans to use partnerships and acquisitions to expand further across Western India.
- The acquisition is part of Redcliffe's strategy to expand integrated diagnostics across Western India.
Earlier rounds
- 2024-02 · acquisition
- 2026-06 · acquisition
Up against
Dr Lal PathLabsMedGenomeNeuberg Diagnostics
Words to know
- MRI
- Magnetic Resonance Imaging, a medical imaging technique used to create detailed pictures of organs and tissues inside the body.
- Omnichannel
- A business approach that provides a seamless customer experience across multiple channels, such as physical centres, online booking, and home collection.
- Phlebotomist
- A trained healthcare professional who draws blood from patients for medical testing.
- Pincode
- A postal code used in India to identify a specific geographic area for mail delivery.
The numbers around it
Redcliffe Labs has 4 funding rounds in StopDown's archive, $115 Mn raised in all.
| When | Round | Amount | Led by |
|---|---|---|---|
| 17 September 2024 | Series C | $42M | IFU (Denmark's Investment Fund for Developing Countries) |
| 13 August 2023 | growth | $80 million | |
| 29 September 2022 | Series B | $100-125 million | |
| 6 May 2022 | Series B | $61M | LeapFrog Investments |
Healthcare & Life Sciences in August 2026: 10 rounds with a disclosed amount, $139 million in all; the biggest was Biodeal Pharmaceuticals (₹385 crore). Every sector this year →
Other articles talking about it
Terms in this story
- Mergers and acquisitions: An acquisition is when one company buys another, and a merger is when two companies combine into one. For most Indian startups a sale is a likelier exit than an IPO, and the Competition Commission of India (CCI) must approve deals that cross its asset, turnover or ₹2,000 crore deal-value limits.
Read next
FundingRedcliffe Lifetech raises $61 million Series BRedcliffe Lifetech is an omnichannel diagnostics platform offering 3,500+ pathology and genetic testsFundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centres
Everything on Redcliffe Labs → · All startup news on 11 August 2026 →
Is this Redcliffe Labs? Get your “Featured on StopDown” badge →